Lv340
400 积分 2025-12-10 加入
Optimization of the simultaneous determination of imatinib and its major metabolite, CGP74588, in human plasma by a rapid HPLC method using D-optimal experimental design
18天前
已完结
Determination of Imatinib Plasma Levels by High Performance Liquid Chromatography (HPLC): Evaluation of Pharmacokinetic Variability and Haematological Consequences
18天前
已关闭
Emerging pharmacotherapy for inflammatory bowel diseases
20天前
已完结
Novel simultaneous analysis of 18 types of glycosaminoglycan-derived disaccharides using 4-aminobenzoic acid ethyl ester derivatization by HPLC with fluorescence detection
24天前
已完结
Emerging pharmacotherapy for inflammatory bowel diseases
26天前
已关闭
Emerging pharmacotherapy for inflammatory bowel diseases
29天前
已完结
Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art
1个月前
已完结
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019
1个月前
已完结
Quantification of the janus kinase 1 inhibitor upadacitinib in human plasma by LC-MS/MS
1个月前
已完结
Quantification of an Anti-Rheumatic Agent: Upadacitinib in Biological Fluid (Plasma) By LC- MS/MS
1个月前
已关闭
Anti-Müllerian hormone induces a reversible quiescence-associated secretory phenotype in preantral follicles
皖公网安备34019202002308
